4.7 Article

The epidemiology of depression in metropolitan China

期刊

PSYCHOLOGICAL MEDICINE
卷 39, 期 5, 页码 735-747

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0033291708004091

关键词

Co-morbidity; epidemiology; major depression; metropolitan China; suicide; treatment

资金

  1. United States National Institute of Mental Health [R01MH070884]
  2. John D. and Catherine T. MacArthur Foundation
  3. Pfizer Foundation
  4. US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
  5. Fogarty International Center [FIRCA R01-TW006481]
  6. Pan American Health Organization
  7. Eli Lilly and Company
  8. Ortho-McNeil Pharmaceutical, Inc.
  9. GlaxoSmithKline
  10. Bristol-Myers Squibb
  11. Sanofi Aventis

向作者/读者索取更多资源

Background. Previous surveys on depression in China focused on prevalence estimates Without providing a detailed epidemiological profile. Method. Face-to-face household interviews were conducted With a multi-stag(2 household probability sample of 2633 adults (age >= 18 years) in Beijing and 2568 in Shanghai between November 2001 and February 2002. The World Health Organization Composite International Diagnostic Interview (CIDI) was used to assess major depressive episode (MDE) according to Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria. Results. The lifetime prevalence and 1-year prevalence estimates of DSM-IV/CIDI MDE were 3.6% [95% confidence interval (CI) 2.8-4.4%] and 1.8% (95% CI 1.2-2.4%,) respectively. No significant gender difference was found in these estimates. Respondents born in 1967 or later were at elevated lifetime risk compared with respondents born in earlier cohorts. The mean age of onset was 30.3 years. Among those reporting 1-year MDE, 15.7, 51.8, 25.3 and 6.4% reported mild, moderate, severe and very severe symptoms, respectively; 4.8, 2.6 and 3.2%, reported suicidal ideation, plans, and recent attempts in the same year respectively. Respondents with 1-year MDE reported a mean of 27.5 days Out of role owing to their depression it) the year before interview. Significant co-morbidity was found between MDE and other mental disorders [odds ratio (OR) 22.0] and chronic physical disorders (OR 3.2). Only 22.7%, of respondents with 1-year MDE Sought treatment. Conclusions. The low prevalence and insignificant gender difference, but not patterns of onset, course, co-morbidity and impairment, distinguish the epidemiological profile of MDE in metropolitan China from those in other countries.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据